DHEA Supplementation Confers No Additional Benefit to that of Growth Hormone on Pregnancy and Live Birth Rates in IVF Patients Categorized as Poor Prognosis

DHEA Supplementation Confers No Additional Benefit to that of Growth Hormone on Pregnancy and Live Birth Rates in IVF Patients Categorized as Poor Prognosis

BackgroundIn vitro fertilization (IVF) patients receive various adjuvant therapies to enhance success rates, but the true benefit is actively debated. Growth hormone (GH) and dehydroepiandrosterone (DHEA) supplementation were assessed in women undergoing fresh IVF transfer cycles and categorized as...

Full description

Bibliographic Details
Main Authors: Kevin N. Keane, Peter M. Hinchliffe, Philip K. Rowlands, Gayatri Borude, Shanti Srinivasan, Satvinder S. Dhaliwal, John L. Yovich
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-01-01
Series:Frontiers in Endocrinology
Subjects:
growth hormone
dehydroepiandrosterone
in vitro fertilization
embryo quality
adjuvants
Online Access:http://journal.frontiersin.org/article/10.3389/fendo.2018.00014/full

Similar Items

Similar Items